Skip to main content
. 2022 Nov 15;9:976216. doi: 10.3389/fnut.2022.976216

TABLE 3.

Univariate and multivariate Cox regression analysis of clinicopathological characteristics associated with overall survival (OS) in colorectal cancer (CRC) patients.

Characteristic Overall survival

Univariate analysis Multivariate analysis


HR (95% CI) P-value HR (95% CI) P-value
Gender (Female) 1.013 (0.857–1.198) 0.881
Age (≥60 years) 1.344 (1.141–1.583) <0.001 1.356 (1.145–1.606) <0.001
BMI 0.060 0.579
 Low Ref. Ref.
 Normal 0.858 (0.678–1.085) 0.200 0.919 (0.721–1.171) 0.492
 High 0.73 (0.56–0.952) 0.020 0.864 (0.656–1.138) 0.299
Hypertension (Yes) 1.202 (0.976–1.48) 0.084
Diabetes (Yes) 1.188 (0.865–1.632) 0.287
NAR (High) 1.769 (1.444–2.167) <0.001 1.280 (1.026–1.596) 0.029
pT stage (T3–4) 2.495 (1.975–3.151) <0.001 1.464 (1.138–1.885) 0.003
pN stage <0.001 <0.001
N0 Ref. Ref.
N1 1.875 (1.544–2.277) <0.001 1.519 (1.242–1.859) <0.001
N2 4.079 (3.339–4.983) <0.001 2.658 (2.127–3.32) <0.001
Distant metastasis (Yes) 5.609 (4.581–6.866) <0.001 3.186 (2.546–3.987) <0.001
Tumor location (Colon) 0.976 (0.83–1.149) 0.772
Tumor size (≥5 cm) 1.308 (1.112–1.539) 0.001 1.069 (0.901–1.267) 0.444
Perineural invasion (Positive) 1.713 (1.359–2.159) <0.001 1.075 (0.829–1.393) 0.587
Vascular invasion (Positive) 2.039 (1.691–2.459) <0.001 1.256 (1.01–1.562) 0.041
Macroscopic type 0.006 0.399
Protrude type Ref.
Infiltrating type 1.448 (1.05–1.997) 0.024 1.175 (0.848–1.627) 0.333
Ulcerative type 1.366 (1.12–1.665) 0.002 1.147 (0.934–1.409) 0.192
Differentiation (High/Medium) 0.648 (0.521–0.807) 0.001 0.789 (0.627–0.993) 0.044
Surgical approach (Laparoscope) 0.648 (0.551–0.763) <0.001 0.89 (0.743–1.066) 0.207
Operating time (median) (≥192 min) 1.21 (1.028–1.426) 0.022 1.075 (0.904–1.278) 0.413
Blood loss (median) (≥100 ml) 1.263 (1.059–1.506) 0.009 1.104 (0.916–1.331) 0.298
CEA (≥5 ng/ml) 2.036 (1.73–2.397) <0.001 1.472 (1.236–1.754) <0.001
Radiotherapy (Yes) 0.939 (0.705–1.252) 0.67
Chemotherapy (Yes) 1.047 (0.889–1.233) 0.581

CRC, colorectal cancer; BMI, body mass index; NAR, neutrophil-albumin ratio.